This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
source: pixabay.com

This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients

Lupus nephritis causes kidney inflammation and can often lead to chronic kidney disease (CKD). An issue that medical professionals have faced is predicting the likelihood of individual patients developing CKD.…

Continue Reading This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
ICYMI: Levodopa Intestinal Gel as a Treatment for Off Periods in Parkinson’s Disease
source: pixabay.com

ICYMI: Levodopa Intestinal Gel as a Treatment for Off Periods in Parkinson’s Disease

According to Parkinson's News Today, an intestinal gel comprised of levodopa and carbidopa (LCIG) is able to lower the amount of time that Parkinson's patients spend in off episodes. These…

Continue Reading ICYMI: Levodopa Intestinal Gel as a Treatment for Off Periods in Parkinson’s Disease
New Drug Application for Niemann-Pick Disease Type C Treatment
source: pixabay.com

New Drug Application for Niemann-Pick Disease Type C Treatment

Orphazyme has recently submitted their New Drug Application to the FDA for their Niemann-Pick disease type C (NPC) treatment, arimoclomol. This application comes after the biopharmaceutical company was already granted…

Continue Reading New Drug Application for Niemann-Pick Disease Type C Treatment
Ankylosing Spondylitis Treatment Approved but Not Yet Available
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

Ankylosing Spondylitis Treatment Approved but Not Yet Available

According to Ankylosing Spondylitis News, a new treatment, Hulio, has been approved by the FDA. It is a treatment for ankylosing spondylitis and other inflammatory disorders. Although it has been…

Continue Reading Ankylosing Spondylitis Treatment Approved but Not Yet Available
Possible New Treatment for Facioscapulohumeral Muscular Dystrophy
source: pixabay.com

Possible New Treatment for Facioscapulohumeral Muscular Dystrophy

A team of researchers from the University of Alberta have created a possible treatment for facioscapulohumeral muscular dystrophy (FSHD). Their work has been published in the Proceedings of the National Academy…

Continue Reading Possible New Treatment for Facioscapulohumeral Muscular Dystrophy
Animal Study Will Evaluate SLS-007 as a Treatment for Parkinson’s Disease
Free-Photos / Pixabay

Animal Study Will Evaluate SLS-007 as a Treatment for Parkinson’s Disease

Researchers at Seelos Therapeutics are planning an animal study to evaluate SLS-007, a treatment for Parkinson's disease. According to an article from Parkinson's News Today, this study is possible after…

Continue Reading Animal Study Will Evaluate SLS-007 as a Treatment for Parkinson’s Disease
Close Menu